Cargando…

Four-way classification of Alzheimer’s disease using deep Siamese convolutional neural network with triplet-loss function

Alzheimer’s disease (AD) is a neurodegenerative disease that causes irreversible damage to several brain regions, including the hippocampus causing impairment in cognition, function, and behaviour. Early diagnosis of the disease will reduce the suffering of the patients and their family members. Tow...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajamohideen, Faizal, Shaffi, Noushath, Mahmud, Mufti, Subramanian, Karthikeyan, Al Sariri, Arwa, Vimbi, Viswan, Abdesselam, Abdelhamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937523/
https://www.ncbi.nlm.nih.gov/pubmed/36806042
http://dx.doi.org/10.1186/s40708-023-00184-w
_version_ 1784890442957979648
author Hajamohideen, Faizal
Shaffi, Noushath
Mahmud, Mufti
Subramanian, Karthikeyan
Al Sariri, Arwa
Vimbi, Viswan
Abdesselam, Abdelhamid
author_facet Hajamohideen, Faizal
Shaffi, Noushath
Mahmud, Mufti
Subramanian, Karthikeyan
Al Sariri, Arwa
Vimbi, Viswan
Abdesselam, Abdelhamid
author_sort Hajamohideen, Faizal
collection PubMed
description Alzheimer’s disease (AD) is a neurodegenerative disease that causes irreversible damage to several brain regions, including the hippocampus causing impairment in cognition, function, and behaviour. Early diagnosis of the disease will reduce the suffering of the patients and their family members. Towards this aim, in this paper, we propose a Siamese Convolutional Neural Network (SCNN) architecture that employs the triplet-loss function for the representation of input MRI images as k-dimensional embeddings. We used both pre-trained and non-pretrained CNNs to transform images into the embedding space. These embeddings are subsequently used for the 4-way classification of Alzheimer’s disease. The model efficacy was tested using the ADNI and OASIS datasets which produced an accuracy of 91.83% and 93.85%, respectively. Furthermore, obtained results are compared with similar methods proposed in the literature.
format Online
Article
Text
id pubmed-9937523
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-99375232023-02-19 Four-way classification of Alzheimer’s disease using deep Siamese convolutional neural network with triplet-loss function Hajamohideen, Faizal Shaffi, Noushath Mahmud, Mufti Subramanian, Karthikeyan Al Sariri, Arwa Vimbi, Viswan Abdesselam, Abdelhamid Brain Inform Research Alzheimer’s disease (AD) is a neurodegenerative disease that causes irreversible damage to several brain regions, including the hippocampus causing impairment in cognition, function, and behaviour. Early diagnosis of the disease will reduce the suffering of the patients and their family members. Towards this aim, in this paper, we propose a Siamese Convolutional Neural Network (SCNN) architecture that employs the triplet-loss function for the representation of input MRI images as k-dimensional embeddings. We used both pre-trained and non-pretrained CNNs to transform images into the embedding space. These embeddings are subsequently used for the 4-way classification of Alzheimer’s disease. The model efficacy was tested using the ADNI and OASIS datasets which produced an accuracy of 91.83% and 93.85%, respectively. Furthermore, obtained results are compared with similar methods proposed in the literature. Springer Berlin Heidelberg 2023-02-17 /pmc/articles/PMC9937523/ /pubmed/36806042 http://dx.doi.org/10.1186/s40708-023-00184-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Hajamohideen, Faizal
Shaffi, Noushath
Mahmud, Mufti
Subramanian, Karthikeyan
Al Sariri, Arwa
Vimbi, Viswan
Abdesselam, Abdelhamid
Four-way classification of Alzheimer’s disease using deep Siamese convolutional neural network with triplet-loss function
title Four-way classification of Alzheimer’s disease using deep Siamese convolutional neural network with triplet-loss function
title_full Four-way classification of Alzheimer’s disease using deep Siamese convolutional neural network with triplet-loss function
title_fullStr Four-way classification of Alzheimer’s disease using deep Siamese convolutional neural network with triplet-loss function
title_full_unstemmed Four-way classification of Alzheimer’s disease using deep Siamese convolutional neural network with triplet-loss function
title_short Four-way classification of Alzheimer’s disease using deep Siamese convolutional neural network with triplet-loss function
title_sort four-way classification of alzheimer’s disease using deep siamese convolutional neural network with triplet-loss function
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937523/
https://www.ncbi.nlm.nih.gov/pubmed/36806042
http://dx.doi.org/10.1186/s40708-023-00184-w
work_keys_str_mv AT hajamohideenfaizal fourwayclassificationofalzheimersdiseaseusingdeepsiameseconvolutionalneuralnetworkwithtripletlossfunction
AT shaffinoushath fourwayclassificationofalzheimersdiseaseusingdeepsiameseconvolutionalneuralnetworkwithtripletlossfunction
AT mahmudmufti fourwayclassificationofalzheimersdiseaseusingdeepsiameseconvolutionalneuralnetworkwithtripletlossfunction
AT subramaniankarthikeyan fourwayclassificationofalzheimersdiseaseusingdeepsiameseconvolutionalneuralnetworkwithtripletlossfunction
AT alsaririarwa fourwayclassificationofalzheimersdiseaseusingdeepsiameseconvolutionalneuralnetworkwithtripletlossfunction
AT vimbiviswan fourwayclassificationofalzheimersdiseaseusingdeepsiameseconvolutionalneuralnetworkwithtripletlossfunction
AT abdesselamabdelhamid fourwayclassificationofalzheimersdiseaseusingdeepsiameseconvolutionalneuralnetworkwithtripletlossfunction
AT fourwayclassificationofalzheimersdiseaseusingdeepsiameseconvolutionalneuralnetworkwithtripletlossfunction